Search results for "Diabetes"


 
Results 11 - 20 of about 960 for "Diabetes".
Sort by: Relevance | Newest | Oldest

SGLT-2 inhibitors reduced gout flares in patients with diabetes, gout

New users of sodium-glucose cotransporter-2 (SGLT-2) inhibitors had about half the risk of an ED visit or hospitalization for a gout flare as matched patients taking dipeptidyl peptidase-4 inhibitors, a cohort analysis found.
https://immattersacp.org/weekly/archives/2023/07/25/1.htm
25 Jul 2023

Taking a weight off diabetes care

Not only is the focus on weight not beneficial to diabetes patients, it can cause other health consequences such as weight cycling and eating disorders.
https://immattersacp.org/archives/2020/09/taking-a-weight-off-diabetes-care.htm
1 Sep 2020

Overweight, obesity poorly managed in type 1 diabetes

While U.S. adults with type 1 diabetes have rates of overweight and obesity virtually identical to those in the general adult population, only about 50% received lifestyle recommendations for weight management from clinicians or tried lifestyle modifications.
https://immattersacp.org/weekly/archives/2023/02/14/4.htm
14 Feb 2023

NOACs linked to lower rates of diabetes complications than warfarin in patients with afib and diabetes

A retrospective study from Taiwan found that patients who received non-vitamin K antagonist oral anticoagulants (NOACs) developed fewer macrovascular and microvascular complications, had fewer glycemic emergencies, and were less likely to die than those who received warfarin.
https://immattersacp.org/weekly/archives/2022/02/15/2.htm
15 Feb 2022

Latest updates on ACP's priorities, initiatives

ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, I.M. Matters Weekly from ACP.
https://immattersacp.org/archives/2024/03/latest-updates-on-acps-priorities-initiatives.htm
1 Mar 2024

Large review compares benefits, harms of drugs to treat type 2 diabetes

High-certainty evidence indicated that sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists reduce all-cause death, while finerenone probably also reduced mortality based on moderate-certainty evidence.
https://immattersacp.org/weekly/archives/2023/04/18/4.htm
18 Apr 2023

Take a team approach to coronary disease

A major update to a cardiology guideline puts team-based, patient-centered care at the forefront of management and highlights the role of healthy diet and exercise habits in reducing cardiovascular risk.
https://immattersacp.org/archives/2024/02/take-a-team-approach-to-coronary-disease.htm
1 Feb 2024

Gestational diabetes associated with risks later in life, but lifestyle makes a difference, studies find

A review found increased risks of cardiovascular and cerebrovascular disease in women who had gestational diabetes, while another study showed that five markers of a healthy lifestyle were associated with a significant reduction in risk of developing type 2 diabetes after gestational diabetes.
https://immattersacp.org/weekly/archives/2022/09/27/4.htm
27 Sep 2022

Points on providing gender-affirming care

There are simple things that physicians can do, regardless of their practice setting, to communicate to patients that they are safe in the clinical space.
https://immattersacp.org/archives/2024/02/points-on-providing-gender-affirming-care.htm
1 Feb 2024

Nocturnal hypoglycemia underdiagnosed in older patients on insulin for type 2 diabetes

An industry-funded study of patients ages 75 years and older who were taking insulin for type 2 diabetes found that almost two-thirds (65.2%) experienced nocturnal hypoglycemia during a 28-day study period.
https://immattersacp.org/weekly/archives/2023/04/04/1.htm
4 Apr 2023

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next